Accord BioPharma’s Biosimilar IMULDOSA gains USFDA approval for treatment of chronic inflammatory conditions Read more
University of Central Lancashire partners with Brinton Healthcare UK to explore nanoparticle technology for skin disease treatment Read more
Aerogen and Indian Association of Respiratory Care sign MoU to advance respiratory therapy education in India Read more
MILOS study highlights potential of bempedoic acid to advance dyslipidemia treatment: GlobalData Read more